Novel SGLT2 inhibitor: first-in-man studies of antisense compound is associated with unexpected renal effects.
about
Novel SGLT2 inhibitor: first-in-man studies of antisense compound is associated with unexpected renal effects.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Novel SGLT2 inhibitor: first-i ...... with unexpected renal effects.
@ast
Novel SGLT2 inhibitor: first-i ...... with unexpected renal effects.
@en
type
label
Novel SGLT2 inhibitor: first-i ...... with unexpected renal effects.
@ast
Novel SGLT2 inhibitor: first-i ...... with unexpected renal effects.
@en
prefLabel
Novel SGLT2 inhibitor: first-i ...... with unexpected renal effects.
@ast
Novel SGLT2 inhibitor: first-i ...... with unexpected renal effects.
@en
P2093
P2860
P356
P1476
Novel SGLT2 inhibitor: first-i ...... with unexpected renal effects
@en
P2093
Adam Cohen
Jacobus Burggraaf
Marieke de Kam
Marloes van Dongen
Matthijs Moerland
P2860
P304
P356
10.1002/PRP2.292
P577
2017-01-17T00:00:00Z